Professor, Pathology, Stanford University Medical Center
Internal Medicine
Dr. Lawrence T. Goodnough, MD
|
|
Give Review
Doctor Lawrence T. Goodnough, MD works in the field of Internal Medicine. He studied medicine at University of Alabama Medical Center. University of Alabama Medical Center is ranked 37 in research and 17 in primary care medicine Doctor Lawrence T. Goodnough, MD is a published MD. He published 85 publications, including: 'The Judicious Use of Recombinant Factor VIIa.'
Publications
- The Judicious Use of Recombinant Factor VIIa.
- Transfusion and coagulation management in major obstetric hemorrhage.
- How I use fibrinogen replacement therapy in acquired bleeding.
- Blood utilization and hemoglobin levels in cancer patients after label and coverage changes for erythropoiesis-stimulating agents.
- Restrictive blood transfusion practices are associated with improved patient outcomes.
- Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
- Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia.
- Case report of a transfusion-associated hepatitis A infection.
- A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
- Can blood transfusion be not only ineffective, but also injurious?
- Perioperative and transfusion outcomes in women undergoing cesarean hysterectomy for abnormal placentation.
- Improved blood utilization using real-time clinical decision support.
- Open aortic valve replacement in a patient with Glanzmann's thrombasthenia: a multidisciplinary strategy to minimize perioperative bleeding.
- Concepts of blood transfusion in adults.
- Blood management: transfusion medicine comes of age.
- Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
- Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis.
- Logistics of transfusion support for patients with massive hemorrhage.
- Iron: The new advances in therapy.
- Update on erythropoiesis-stimulating agents.
- Current Status of Pharmacologic Therapies in Patient Blood Management.
- A Reappraisal of Plasma, Prothrombin Complex Concentrates, and Recombinant Factor VIIa in Patient Blood Management.
- Use of point-of-care testing for plasma therapy.
- Blood ordering from the operating room: turnaround time as a quality indicator.
- Patient Blood Management.
- How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products.
- Iron deficiency syndromes and iron-restricted erythropoiesis.
- Operational, Quality, and Risk Management in the Transfusion Service: Lessons Learned.
- A novel allocation strategy for blood transfusions: investigating the tradeoff between the age and availability of transfused blood.
- Massive Transfusion Protocols for Patients With Substantial Hemorrhage.
- Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
- How we treat: transfusion medicine support of obstetric services.
- How we treat management of warfarin-associated coagulopathy in patients with intracerebral hemorrhage.
- Quality management in the transfusion service: case studies in process improvement.
- Detection, evaluation, and management of iron-restricted erythropoiesis.
- Erythropoiesis stimulating agents, blood transfusion, and the practice of medicine.
- Blood transfusion as a quality indicator in cardiac surgery.
- Age of blood as a limitation for transfusion: potential impact on blood inventory and availability.
- Impact of cytomegalovirus (CMV) antibody reflex testing in the transfusion service on management of CMV-seronegative blood inventory.
- Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting.
- Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
- Improving platelet supply chains through collaborations between blood centers and transfusion services.
- The new age of iron: evaluation and management of iron-restricted erythropoiesis.
- Implementation of a two-specimen requirement for verification of ABO/Rh for blood transfusion.
- A case of no pain and no gain from blood?
- Why an alternative to blood transfusion?
- The role of intravenous iron in anemia management and transfusion avoidance.
- Alloimmunization to red blood cell antigens affects clinical outcomes in liver transplant patients.
- A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
- Transfusion triggers.
- Update on transfusion medicine.
- How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol.
- Recombinant factor VIIa: safety and efficacy.
- Blood management.
- Objectives and limitations of bloodless medical care.
- A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to unt...
- Anemia screening in elective surgery: definition, significance and patients' interests.
- Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.
- Detection, evaluation, and management of anemia in the elective surgical patient.
- Risks of blood transfusion.
- Anemia of chronic disease.
- Rationale for blood conservation.
- Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma.
- Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.
- Transfusion medicine service policies for recombinant factor VIIa administration.
- Blood and blood conservation: a national perspective.
- Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic t...
- Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature.
- Anemia and its clinical consequences in patients with chronic diseases.
- Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia?
- Experiences with recombinant human factor VIIa in patients with thrombocytopenia.
- Joint ASH and AABB educational session.
- Patient safety and blood transfusion: new solutions.
- Anemia: not just an innocent bystander?
- Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: a...
- Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.
- Bloodless medicine: clinical care without allogeneic blood transfusion.
- Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell trans...
- Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
- The rise and fall of preoperative autologous blood donation (editorial). Transfusion. 2001;41:1459-62.
- Issues in the management of cancer-related thrombocytopenia.
- Red cell growth factors in patients with chronic anemias.
- Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received acti...
- Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial.
Schools
Perelman School of Medicine University of Pennsylvania
Doctors Specialties
- Blood Banking
- Hematology
- Medical Oncology
- Oncology
- Internal Medicine
Accepted Insurances
Education
-
University of Alabama Medical Center -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Stanford Health Care -
Lucile Packard Children's Hospital Stanford
Helpful Reviews
Similar Doctors
|
|
Dr. Alexis L. Crawley, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel L. Kraft, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cheryl C. Bates, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles Liao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tyler P. Johnson, MD |
|
|
Dr. Errol Ozdalga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Arber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shruti N. Sheth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruno C. Medeiros, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajat Rohatgi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren S. Maeda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott D. Boyd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nam Q. Bui, MD |
|
|
Dr. Laura J. Johnston, MD |
|
|
Dr. Margaret J. Neff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert S. Ohgami, MD
This Doctor is OpenDoctor Recommended.
|